Impact Biomedical, Inc. · AMEX:IBO
Impact Biomedical — Investor Presentation (November 2024)
10 slides from Impact Biomedical's investor presentation, Nov 4, 2024
Slide 1: Impact Biomedical, Inc.
“alt. IMPACT BIOMEDICAL, INC. ve Jinpactlomedne.com Sparano Contre
Slide 2: Safe Harbor
ill. SAFE HARBOR seem This presentation contains certain forward-looking statements within the meaning of the federal securities laws. These statements may be made a part of this presentation or by reference to other documents we file with the SEC, Some of the forward-looking statements can be ident
Slide 3: Impact Biomedical Inc. (IBO:NYSE American)
“allt. Impact Biomedical Inc. (IBO:NYSE American) "'"""" + Search & Discover oe * Validate & Patent ~ New Solutions in Human Healthcare & Weliness + Partner & Create Value Biotech/Med-Tech (row/emaresuistes) Consumer/OTC & DTC Emerging Technology © Anti-Virals * BioPharmaceuticals > Health & Wellnes
Slide 4: BioPharmaceuticals: Linebacker (LB)
Yi LINEBACKER LUNG CANCER OS ae COLON CANCER GP teeter combination therapy. eS) “OTHER APPLICATIONS, BioPharmaceuticals: LINEBACKER™ (LB) Polyphenol/ Modified Myricetin: Plant derived flavonoid THERAPEUTIC POTENTIAL* Commercial Development / IP =~ « Partner: ProPhase Labs (NASDAQ: PRPH) poypHenots _
Slide 5: BioPharmaceutical and Consumer/OTC: Laetose
Sugar Reduction Substitute Dietary Supplement Therapeutics BioPharmaceutical and Consumer/OTC: Laetose™ « Combination of multiple sugars and inositol. 3 yy eere ™ ee 9 BENERTS OF » Demonstrates ability to inhibit the I IL inflammatory and metabolic response of sugar @ SUPPLEMENTATION > alone. t 2 I»
Slide 6: Consumer/OTC: Equivir /G (Flavonoids)
+ Novel blend(s): = Myricetin = Piperine = Hesperitin = Gallic Acid NATURALLY-SOURCED ORIGIN Ge ( @ Consumer/OTC: EQUIVIR™ /G (FLAVONOIDS) » Generally recognized as safe (GRAS) polyphenols. Commercial Development/ IP. + Partner: ProPhase Labs (NASDAQ: PRPH) Ce eget + Initial Target Application: OTC
Slide 7: Consumer/OTC: 3F Functional Fragrances
Consumer/OTC: 3F™ FUNCTIONAL FRAGRANCES + Suite of “functional fragrances” containing specialized botanical ingredients (e.g., terpenes) NATURALLY-SOURCED ORIGIN Commercial DEVELOPMENT / IP + Partner: Chemia Corp. St. Louis, MO APPLICATIONS / INDICATION - Manufacturing Established (Repellents/Anti-V
Slide 8: Leadership Team
Leadership Team Frank D. Heuszel CEO Frank D. Heuszel brings experience in executive leadership, finance, and strategic pla BioMedical. Prior to joi had a successful eareer mercial ban ‘Administration from The University of Texas at Au and a J.D. degree from The South Texas Colle Houston, ‘wwnw.Impa
Slide 9: Why Invest in Impact Biomedical?
. oa] if It Attractive Valuation/Potential Shareholder IMPACT BIOMEDICAL, INC. Appreciation Unique Early-Stage Diversified Healthcare Company: Bio-tech/Med-Tech Regulated Consumer (OTC) WHY INVEST IN Novel Intellectual Property Worldwide: IMPACT Pera laa Fifty (50)+ Pending Worldwide Patents BIOMEDI
Slide 10: Impact Biomedical, Inc. Contact
veal Tts. IMPACT BIOMEDICAL, INC. www.|impactBiomedIinc.com FOR MORE INFORMATION CONTACT: FRANK)D. HEUSZEL, President & CEO fheusze!@impactbiomedinc.com / +1 (281) 415-6576
Impact Biomedical — Investor Presentation (November 2024) on 6ix